Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Patricia Ging

Transplant and pulmonary hypertension pharmacist at Mater Misericordiae University Hospital in Dublin, Ireland

Recent stories

  • Shiny toughened skin on hands suffering from scleroderma (systemic sclerosis)

    Scleroderma: managementSubscription

    17 DEC 2014

    There are few evidence-based guidelines for the treatment of scleroderma, and its wide range of potential complications means many different medicines can be used in treatment.

  • Idiopathic pulmonary fibrosis: Clinical features and diagnosisSubscription

    CP, 2013

    diopathic pulmonary fibrosis (IPF) is one of a large group of conditions, collectively referred to as interstitial lung diseases, that are similar in clinical and radiological presentation. Although the cause of IPF is unknown, several risk factors — such as environmental exposure to harmful substances and viral infection — have been suggested 

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.